Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions

NCT04540900 is registered in ClinicalTrials.gov with Krystal Biotech, Inc. as lead sponsor.

NCT NCT04540900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04540900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
Lead sponsor
Krystal Biotech, Inc.
Phase
Phase 1
Overall status
Active, not recruiting
Start date
October 7, 2020
Completion date
May 31, 2029
Enrollment
85 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

fine lines, skin roughness, skin thickness, wrinkle